OtoPrep

White Oral Lesions: the Wipe Test Algorithm for ENT Boards

Posted on by OtoPrep
High-Yield Deep-Dive • Head & NeckFRCS (ORL-HNS) + ABOHNS + EBEORL-HNS relevant

White Oral Lesions: the wipe test algorithm for ENT boards.

A white plaque in the mouth is not a diagnosis. The high-yield approach is to wipe it, pattern it, assess risk, treat what is treatable, and biopsy or refer what persists.

Start ABOHNS free trialMock papers hubENT subscriptions

Exam line: “White plaque + no diagnosis = don’t just reassure.”

White oral lesions overview comparing oral candidiasis, leukoplakia and oral lichen planus with a wipe test approach.
Carousel cover image: white oral lesions compared by wipe test, pattern, risk and biopsy threshold.

The 60-second overview: how to pattern white oral lesions

For board questions, do not start by memorising every possible white lesion. Start with the algorithm.

Core algorithm:

  1. Can it be wiped off? If yes, think pseudomembranous candidiasis first.
  2. Where is it? Buccal mucosa, lateral tongue and floor of mouth carry different implications.
  3. Is it symmetric? Bilateral lacy lesions favour classic oral lichen planus.
  4. Is there red, ulcerated or indurated change? Lower your biopsy/referral threshold.
  5. Did it respond to appropriate treatment? Treat the treatable, but review the response.
OtoPrep pearl:
treat the treatable → review → biopsy or refer the persistent.
Board-style algorithm for a white oral lesion using wipe test, site, symmetry, risk factors and biopsy referral threshold.
Board-style algorithm: wipe test first, then site, symmetry, red flags and response to treatment.
Important clinical note: This is educational content for exam preparation and pattern recognition. Persistent, atypical or suspicious oral lesions require appropriate clinical assessment, specialist referral and/or biopsy according to local pathways.

Step 1: the wipe test

The first practical question in a white oral lesion stem is simple: does the plaque wipe off?

Step one wipe test for white oral lesions showing lesions that wipe off, do not wipe off and high-risk features.
The wipe test separates pseudomembranous candidiasis from persistent non-wipeable lesions that need patterning and follow-up.
Wipe test result Most important board interpretation Next step mindset
Wipes off Pseudomembranous candidiasis rises to the top. Treat candidiasis, address risk factors, then review.
Doesn’t wipe off Do not automatically call it leukoplakia. Pattern the lesion: lichen planus, frictional keratosis, hyperplastic candidiasis, dysplasia and leukoplakia are all in play.
Red, speckled, ulcerated or indurated Higher-risk morphology. Biopsy/referral threshold should be low.
Board trap: “Non-wipeable” does not equal “benign”. It means you now need a diagnosis — or a biopsy/referral plan.

Oral candidiasis: the white lesion that may wipe off

Pseudomembranous candidiasis is the classic “white plaques that scrape away” diagnosis — but candidiasis is not always white and not always wipeable.

Pseudomembranous

  • White plaques
  • Usually wipe off
  • Often leaves an erythematous base

Erythematous / atrophic

  • Red sore mucosa
  • Burning symptoms
  • Often linked with dentures or antibiotics

Hyperplastic

  • White plaque
  • May not wipe off
  • Can mimic leukoplakia
Risk factors to look for:

  • Inhaled or topical corticosteroids
  • Recent antibiotics
  • Denture wear or poor denture hygiene
  • Diabetes or immunosuppression
  • Xerostomia or reduced salivary flow
Exam line: “Wipes off → treat candidiasis and address the risk factor. If it persists after appropriate therapy, reassess and consider biopsy/referral.”
Oral candidiasis infographic showing pseudomembranous, erythematous atrophic and hyperplastic candidiasis with risk factors.
Candidiasis pattern: pseudomembranous lesions wipe off; hyperplastic candidiasis can be a non-wipeable mimic.

Oral lichen planus: bilateral lacy Wickham striae

Classic reticular oral lichen planus is a pattern diagnosis: bilateral, symmetric, lacy white lines, especially on the buccal mucosa.

Oral lichen planus infographic showing bilateral lacy Wickham striae, reticular and erosive atrophic patterns and management.
Classic oral lichen planus: bilateral lacy Wickham striae. Atypical or unilateral disease needs more caution.
Pattern Board clues Management mindset
Reticular OLP Bilateral, symmetric, lacy Wickham striae; commonly buccal mucosa; often painless. Pattern diagnosis when classic; review and monitor.
Erosive / atrophic OLP Burning, pain, erythema, ulcerated areas with a white lacy border. Symptomatic disease is often treated with topical corticosteroid therapy under appropriate supervision.
Unilateral or atypical “OLP” One-sided, irregular, isolated or changing lesion; may sit near dental restorations or look dysplastic. Think lichenoid reaction, contact reaction, drug reaction or dysplasia; biopsy/referral threshold is lower.
Board trap: Do not use “lichen planus” as a comforting label when the lesion is unilateral, ulcerated, indurated or not behaving like classic bilateral reticular OLP.

Leukoplakia: non-wipeable white plaque is a diagnosis of exclusion

Leukoplakia is not just “any white patch”. It is the pathway you enter after excluding other definable causes of a persistent white plaque.

Classic leukoplakia pathway:

  • White plaque on oral mucosa.
  • Cannot be wiped off.
  • Not better explained by candidiasis, lichen planus, frictional keratosis, chemical burn, leukoedema or another diagnosis.
  • Persistent after irritants are removed or after the presumed treatable cause has been treated.

Risk factors

  • Smoking or smokeless tobacco
  • Alcohol exposure
  • Chronic irritation
  • High-risk sites: tongue and floor of mouth
  • Non-homogeneous or speckled morphology

Workup mindset

  • Remove irritants
  • Address candidal or traumatic mimics
  • Arrange short-interval review
  • Biopsy if persistent or suspicious
  • Do not reassure without a diagnosis
High-yield red flag: speckled, red-white or erythroleukoplakic lesions are more concerning than a uniform homogeneous white plaque.
Oral leukoplakia infographic showing non-wipeable white plaque, smoking and alcohol risk, lateral tongue, floor of mouth and biopsy if persistent.
Leukoplakia pathway: non-wipeable white plaque after mimics are excluded, with biopsy if persistent or high risk.

Red flags: when a white oral lesion needs biopsy/referral mindset

The board-friendly phrase is: treat what is treatable, but biopsy or refer what is persistent, atypical or high risk.

Finding Why it matters Board-ready next step
Unexplained oral ulceration lasting >3 weeks Persistent ulceration is a cancer-referral red flag in many pathways. Urgent assessment / suspected cancer pathway according to local guidance.
Red or red-white patch Erythroplakia or erythroleukoplakia carries higher concern than a purely homogeneous white plaque. Urgent dental/oral medicine/ENT assessment and biopsy consideration.
Induration, fixation, rolled border or mass Suggests invasive or more aggressive pathology. Biopsy/referral mindset.
Lateral tongue or floor-of-mouth lesion Higher-risk oral cavity subsites for premalignant/malignant change. Lower threshold for biopsy, especially if persistent or non-homogeneous.
Unilateral “lichen planus” Classic reticular OLP is usually bilateral and symmetric. Consider lichenoid reaction, trauma, dysplasia or malignancy; refer/biopsy if uncertain.
Persistence after appropriate antifungal treatment A presumed candidal lesion should respond; non-response means the diagnosis may be wrong or incomplete. Reassess risk factors, examine carefully and consider biopsy/referral.
Neck node, weight loss, dysphagia or systemic concern Moves the question away from “benign oral lesion” and toward broader head-and-neck assessment. Urgent specialist pathway.
Template sentence: “I would not simply reassure. I would remove obvious irritants or treat candidiasis if appropriate, arrange review, and biopsy/refer if the lesion is persistent, atypical, red-white, ulcerated or indurated.”

Common board traps: candidiasis vs leukoplakia vs lichen planus

The best exam answers show that you can avoid false reassurance and false certainty.

Trap Better answer
“It is white, so it is thrush.” Only pseudomembranous candidiasis classically wipes off. Hyperplastic candidiasis can be non-wipeable and can mimic leukoplakia.
“It doesn’t wipe off, so it is leukoplakia.” Non-wipeable means you must exclude mimics. Leukoplakia is a diagnosis of exclusion.
“Lichen planus is always harmless.” Classic bilateral reticular OLP is a pattern diagnosis, but erosive, ulcerated, unilateral or changing lesions deserve caution and follow-up.
“Give antifungals and move on.” Treat candidiasis, address risk factors and review the response. Persistence changes the plan.
“No pain means no problem.” Many premalignant or malignant oral lesions may be painless early.

Practise this in exam format

Turn pattern recognition into marks with board-style stems, timed sets and analytics across head and neck, rhinology, otology, laryngology and paediatric ENT.

Also available: FRCS free trial · EBEORL-HNS free trial · ENT subscriptions

FAQ: white oral lesions

What is the first question to ask about a white oral lesion?

Ask whether it wipes off. A white plaque that wipes off suggests pseudomembranous candidiasis, especially if it leaves an erythematous base. A non-wipeable lesion needs further patterning and follow-up.

Does a non-wipeable white plaque always mean leukoplakia?

No. Non-wipeable lesions include leukoplakia, oral lichen planus, frictional keratosis, hyperplastic candidiasis and dysplasia or malignancy. Leukoplakia is a diagnosis of exclusion.

What is the classic pattern of oral lichen planus?

Classic reticular oral lichen planus is usually bilateral and symmetric, with lacy Wickham striae, often on the buccal mucosa. Unilateral or atypical lesions should prompt caution.

When should a white oral lesion be biopsied or referred?

Biopsy/referral should be considered for persistent lesions, uncertain diagnosis, red-white or speckled lesions, ulceration, induration, high-risk sites such as lateral tongue or floor of mouth, or failure to respond to appropriate treatment.

What is the board pearl for candidiasis vs leukoplakia?

Wipes off → candidiasis rises to the top. Persistent non-wipeable plaque → do not just reassure; exclude mimics and consider biopsy/referral if it persists or looks high risk.

Selected references and further reading

References are included to support medical accuracy and trust for a health-education page.

  1. NCBI Bookshelf: Oral Candidiasis — presentations, risk factors, wipeable pseudomembranous candidiasis and hyperplastic candidiasis.
  2. NCBI Bookshelf: Oral Leukoplakia — leukoplakia definition, diagnosis of exclusion, potentially malignant nature, risk factors and biopsy principles.
  3. NICE NG12: Suspected cancer recognition and referral — oral ulceration lasting more than 3 weeks and red/red-white oral patches.
  4. American Family Physician: Common Oral Lesions — oral lichen planus pattern recognition, Wickham striae and common oral lesion differentials.
  5. American Family Physician: Diagnosis and Treatment of Lichen Planus — biopsy in atypical cases and topical corticosteroids for mucosal erosive lesions.
  6. Google Search Central: Image SEO best practices — descriptive filenames, image placement, titles and alt text.
  7. Google Search Central: Article structured data — structured data for news, blog and article pages.

Keep learning

Useful next clicks for mocks, trials and structured ENT revision.

Back to top ↑

Educational content only. This page is designed for ENT examination preparation and should not be used as individual medical advice. Follow local guidelines and specialist input for real patients.

OtoPrep

Sinonasal Inverted Papilloma: How to Stage, Map the Attachment, and Reduce Recurrence

Posted on by OtoPrep
OtoPrep High-Yield Deep-Dive • Rhinology FRCS (ORL-HNS) + ABOHNS + EBEORL-HNS relevant

Sinonasal Inverted Papilloma: stage it, find the base, prevent recurrence.

Recurrence is often a technique problem — not “bad luck”. The high-yield move is to map the attachment (often hinted by CT focal hyperostosis), then perform a complete endoscopic resection with base clearance + bone drilling.

Start ABOHNS free trial Mock papers hub ENT subscriptions

Exam line: “Endoscopic resection with identification of the attachment site and drilling/curettage of underlying bone.”

OtoPrep hero illustration showing question bank practice converting into measurable progress and performance trends.
On this page Jump straight to what you need.
Overview Imaging Krouse staging Technique Recurrence reduction Surveillance FAQ

The 60-second overview (what examiners want)

Inverted papilloma is benign on paper — but behaves like a locally aggressive tumour. Your marks come from attaching the right words to the right steps.

Core principles:
  • Unilateral sinonasal mass → think IP until proven otherwise (especially if papillomatous/bleeds).
  • CT focal hyperostosis often points to the attachment site (plan to drill this).
  • Krouse staging describes extent and helps frame the operation (T1/T2 = endoscopic workhorses).
  • Definitive management is complete surgical resection — not “polypectomy”.
  • Long-term endoscopic follow-up is essential (late recurrences happen).
Exam trap: Saying “simple polypectomy” or “observe with scans” after a confirmed IP will lose marks. The standard is complete excision with base clearance.

Educational content only — always follow local guidelines and senior input for real cases.

Imaging pearls: map the base before you pick up the drill

The high-yield imaging job is not “confirm a mass” — it’s “find the attachment and define boundaries”.

CT (bone windows): the attachment clue

  • Focal hyperostosis = common attachment site clue → plan to drill/curette there.
  • Assess sinus walls + corridors (maxillary, ethmoid, frontal recess, sphenoid).
  • Look for bone destruction/irregular erosion (raises concern for malignancy or aggressive behaviour).

MRI: tumour vs secretions + extent

  • Defines skull base/orbital proximity; clarifies “tumour vs trapped mucus”.
  • Classic teaching: convoluted/cerebriform pattern on T2/contrast (useful, not mandatory).
  • Suspicious focal changes may suggest dysplasia/malignant transformation → plan accordingly.
Question you must answer What you look for Why it matters
Where is the attachment? CT focal hyperostosis; intra-op correlation Attachment clearance is the recurrence lever
How far does it extend? Sinuses involved (ethmoid/maxillary/frontal/sphenoid); corridors Determines whether extended endoscopic access is required
Any red flags for malignancy? Irregular bone destruction; extrasinus extension; suspicious enhancement Changes staging, surgical margins, and adjuvant planning
Template sentence (imaging): “CT shows a unilateral sinonasal mass with focal hyperostosis at the suspected attachment site; MRI defines soft-tissue extent and excludes orbital/intracranial extension.”

Krouse staging (the exam-friendly version)

Know the staging well enough to say it out loud without thinking — then link it to the operation.

Krouse stage Extent (high yield) Typical approach framing
T1 Confined to nasal cavity (often lateral nasal wall/middle meatus) Endoscopic excision + base clearance + drilling
T2 Osteomeatal complex / ethmoid ± medial maxillary involvement Endoscopic (often ethmoidectomy + targeted access)
T3 Other maxillary walls and/or frontal/sphenoid involvement Endoscopic extended approaches (e.g., endoscopic medial maxillectomy, Draf where needed)
T4 Extrasinus/extranasal extension or associated malignancy Often combined/open + oncology planning as required
Exam trap: If there is associated carcinoma, the case is effectively “T4” in practice framing — it changes the conversation (oncology work-up, margins, adjuvant therapy).

How to “use” the stage in your answer

  1. State the stage based on extent.
  2. State the principle: complete resection + attachment site clearance.
  3. State the access you need (standard endoscopic vs extended endoscopic vs combined).
Roadmap illustration showing steady progress toward ENT exam readiness.

Surgical technique: the recurrence-proof plan

This is the make-or-break section. The winning answer is a sequence: exposure → identify base → remove tumour → drill base → marsupialise cavities → document follow-up.

One-line exam answer: “Endoscopic resection of IP with identification of the attachment site (often hyperostotic on CT), complete mucosal removal at the base, and drilling/curettage of underlying bone to reduce recurrence.”

Step-by-step operative approach (endoscopic-first)

  1. Pre-op mapping: review CT bone windows for hyperostosis; plan access corridors (maxillary/ethmoid/frontal recess/sphenoid).
  2. Exposure: create working space (uncinectomy, wide middle meatal antrostomy, ethmoidectomy as required).
  3. Identify the attachment: correlate endoscopic findings with imaging clues; don’t be satisfied with “where it’s bulging”.
  4. Resect the tumour: controlled excision (avoid casual piecemeal “polypectomy” mentality).
  5. Clear the base: remove involved mucosa around the attachment; then drill/curette the underlying hyperostotic bone until healthy bone is reached.
  6. Extended access when needed: for maxillary sinus attachment beyond medial wall, consider endoscopic medial maxillectomy (or extended endonasal approaches) to reach all recesses.
  7. Marsupialise for surveillance: widen the surgical cavity so the base and recesses are visible on follow-up endoscopy.
  8. Histology: ensure complete sampling; address dysplasia/malignancy if present (MDT pathway).
Technique mistake that causes recurrence: Removing the “mass” but not the attachment site mucosa and not drilling the hyperostotic base.

When to say “endoscopic medial maxillectomy” (high yield)

Use this term when you need dependable access to maxillary sinus recesses (e.g., anterior/lateral/inferior walls), especially if imaging suggests attachment beyond the medial maxillary wall. The exam point is not the name — it’s the logic: your approach must reach the attachment and allow base drilling.

Scenario What you say Why
T1 (nasal cavity/lateral wall only) Endoscopic excision + base clearance + drilling Limited disease, endoscopic is standard, low morbidity
T2 (OMC/ethmoid ± medial maxillary) Endoscopic ethmoidectomy/antrostomy + targeted base drilling Access corridors let you reach typical attachments
T3 (frontal/sphenoid or maxillary recess attachment) Extended endoscopic approach (e.g., endoscopic medial maxillectomy/Draf) + base drilling Must reach hidden recesses to prevent residual disease
T4 / malignancy / extrasinus extension MDT staging + combined/open as required Oncologic principles and margins dominate

Recurrence reduction: your checklist

Think of recurrence as “residual attachment” until proven otherwise.

Do these:
  • Pre-op: locate hyperostosis and plan access to it.
  • Intra-op: find true attachment, not the bulkiest part.
  • Resect mucosa at attachment with a margin.
  • Drill/curette underlying bone at the base.
  • Open cavities wide enough for clinic visualisation.
  • Document the attachment site in op note (future you will thank you).
Avoid these:
  • “Polypectomy” language or behaviour.
  • Leaving a narrow antrostomy that hides the recesses.
  • Assuming “no bone destruction” = low recurrence risk.
  • Short follow-up (late recurrences exist).

Malignancy risk (what to say)

IP has a recognised risk of dysplasia/malignant transformation. In answers, state: histology review + MDT pathway if carcinoma is found, and ensure follow-up is long-term.

Spaced repetition orbit progress hero illustration.

Surveillance: how to follow these patients (board-ready)

Your follow-up plan should show you understand both recurrence and malignant transformation risk.

Time after surgery What you do Why
0–12 months Regular endoscopic review (more frequent early) Early recurrences and healing-related changes are easiest to catch here
Years 1–5 Ongoing endoscopy; imaging if concern on exam Recurrence can be subtle; clinical exam drives imaging
>5 years Long-term follow-up (often annually) Late recurrence can occur; don’t “discharge at 5 years” by default
Template sentence (follow-up): “I would arrange long-term endoscopic surveillance, with imaging guided by endoscopic findings or symptoms, given the risk of late recurrence and malignant transformation.”

Practise this in exam format

Turn recognition + technique into marks with board-style stems, timed sets, and analytics.

Also available: FRCS free trial · EBEORL-HNS free trial · ENT subscriptions

FAQ

What is a sinonasal inverted papilloma (IP)?

A benign Schneiderian tumour that can behave aggressively locally, with a tendency to recur if incompletely removed and a recognised risk of dysplasia or malignant transformation.

Why is CT hyperostosis important?

Focal hyperostosis on CT bone windows often corresponds to the tumour’s attachment site. Identifying and clearing that base (including drilling/curettage of underlying bone) is a key recurrence-reduction step.

How is Krouse staging used in exams?

It describes disease extent (T1–T4). It helps you justify the surgical access you need — but the principle stays the same: complete resection with attachment site clearance.

What is the definitive management for a T1/T2 inverted papilloma?

Endoscopic excision with identification of the attachment site, removal of involved mucosa, and drilling/curettage of the underlying bone at the base to minimise recurrence.

When should you mention “endoscopic medial maxillectomy”?

When access is needed to maxillary sinus recesses (anterior/lateral/inferior walls) or when imaging suggests the attachment sits beyond the medial maxillary wall. The key is that your approach must reach the base for complete clearance.

How long should patients be followed?

Long-term endoscopic surveillance is recommended because recurrences can be late. Imaging is guided by symptoms or suspicious endoscopic findings.

Keep learning

Useful next clicks for mocks, trials, and structured revision.

Back to top ↑